Health Care & Life Sciences » Pharmaceuticals | Apricus Biosciences Inc.

Apricus Biosciences Inc. | Ownership

Companies that own Apricus Biosciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Iroquois Capital Management LLC
656,918
2.8%
241,477
0.82%
12/31/2017
Sarissa Capital Management LP
480,000
2.04%
-967,906
0.03%
09/04/2018
The Vanguard Group, Inc.
325,398
1.39%
-138,650
0%
06/30/2018
Geode Capital Management LLC
228,416
0.97%
203,463
0%
06/30/2018
K2/D&S Management Co. LLC
105,890
0.45%
23,696
0.01%
06/30/2018
Healthcare Value Capital LLC
100,000
0.43%
0
0.1%
06/30/2018
BlackRock Fund Advisors
87,036
0.37%
0
0%
06/30/2018
Virtu Financial BD LLC
38,126
0.16%
27,936
0%
06/30/2018
The California Public Employees Retirement System
25,813
0.11%
0
0%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
21,001
0.09%
8,938
0%
06/30/2018

About Apricus Biosciences

View Profile
Address
11975 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.apricusbio.com
Updated 09/14/2018
Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.